Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sharma

Showing results (381-390 of 389) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 389 results.
Frontiers in Public Health|December 16, 2020
Protocol for a Case-Control Study to Investigate the Association of Pellagra With Isoniazid Exposure During Tuberculosis Preventive Treatment Scale-Up in MalawiScott A Nabity, Kelvin Mponda, Steve Gutreuter, et al.
Cancer Cell|April 22, 2023
Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancerClare E Weeden, Velimir Gayevskiy, Claire Marceaux, et al.
International Journal of Obesity (2005)|May 3, 2018
Maternal smoking during pregnancy and offspring overweight: is there a dose-response relationship? An individual patient data meta-analysisLucia Albers, Christina Sobotzki, Oliver Kuß, et al.
The Lancet. Global Health|April 15, 2022
Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control studyScott A Nabity, Kelvin Mponda, Steve Gutreuter, et al.
Clinical and Translational Medicine|March 12, 2025
Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expressionJacklyn Liu, Helen Bewicke-Copley, Shruti Patel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]A Arora, H Bhaskarane, G Tansir, et al.
Epilepsia|June 12, 2016
Rasmussen encephalitis tissue transfer programCarol A Kruse, Carlos A Pardo, Adam L Hartman, et al.
JAMA Neurology|December 27, 2022
Association of Endovascular Thrombectomy vs Medical Management With Functional and Safety Outcomes in Patients Treated Beyond 24 Hours of Last Known Well: The SELECT Late StudyAmrou Sarraj, Timothy J Kleinig, Ameer E Hassan, et al.
Persoonia|September 26, 2019
Fungal Planet description sheets: 868-950P W Crous, A J Carnegie, M J Wingfield, et al.
Pageof 39

Showing results (381-390 of 389) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 389 results.
Frontiers in Public Health|December 16, 2020
Protocol for a Case-Control Study to Investigate the Association of Pellagra With Isoniazid Exposure During Tuberculosis Preventive Treatment Scale-Up in MalawiScott A Nabity, Kelvin Mponda, Steve Gutreuter, et al.
Cancer Cell|April 22, 2023
Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancerClare E Weeden, Velimir Gayevskiy, Claire Marceaux, et al.
International Journal of Obesity (2005)|May 3, 2018
Maternal smoking during pregnancy and offspring overweight: is there a dose-response relationship? An individual patient data meta-analysisLucia Albers, Christina Sobotzki, Oliver Kuß, et al.
The Lancet. Global Health|April 15, 2022
Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control studyScott A Nabity, Kelvin Mponda, Steve Gutreuter, et al.
Clinical and Translational Medicine|March 12, 2025
Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expressionJacklyn Liu, Helen Bewicke-Copley, Shruti Patel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2025
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC]A Arora, H Bhaskarane, G Tansir, et al.
Epilepsia|June 12, 2016
Rasmussen encephalitis tissue transfer programCarol A Kruse, Carlos A Pardo, Adam L Hartman, et al.
JAMA Neurology|December 27, 2022
Association of Endovascular Thrombectomy vs Medical Management With Functional and Safety Outcomes in Patients Treated Beyond 24 Hours of Last Known Well: The SELECT Late StudyAmrou Sarraj, Timothy J Kleinig, Ameer E Hassan, et al.
Persoonia|September 26, 2019
Fungal Planet description sheets: 868-950P W Crous, A J Carnegie, M J Wingfield, et al.
Pageof 39